Decoy Therapeutics Inc. (DCOY) › Operating IncomeDecoy Therapeutics Inc. (DCOY) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2015: -$29.21M2016: -$39.89M2017: -$34.73M2018: -$1.68M2019: -$8.27M2020: -$7.79M2021: -$12.81M2022: -$31.84M2023: -$12.89M2024: -$5.73M2025: -$12.61M-$12.61M2015Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$12.61M-120.0%2024-$5.73M+55.5%2023-$12.89M+59.5%2022-$31.84M-148.5%2021-$12.81M-64.6%2020-$7.79M+5.8%2019-$8.27M-390.6%2018-$1.68M+95.1%2017-$34.73M+12.9%2016-$39.89M-36.5%2015-$29.21M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share